Pavlik EJ - Search Results

1

Variables Associated With Resolution and Persistence of Ovarian Cysts.

Lasher A, Harris LE, Solomon AL, Harbin LM, Raby L, Dietrich CS, Kryscio RJ, van Nagell JR, Pavlik EJ. Lasher A, et al. Among authors: pavlik ej. Obstet Gynecol. 2023 Dec 1;142(6):1293-1301. doi: 10.1097/AOG.0000000000005411. Epub 2023 Oct 12. Obstet Gynecol. 2023. PMID: 38051292 Clinical Trial.

2

Localization of estrogen receptors in uterine cells. An appraisal of translocation.

Pavlik EJ, Rutledge S, Eckert RL, Katzenellenbogen BS. Pavlik EJ, et al. Exp Cell Res. 1979 Oct 1;123(1):177-89. doi: 10.1016/0014-4827(79)90434-8. Exp Cell Res. 1979. PMID: 488181 No abstract available.

3

Human endometrial cells in primary tissue culture: estrogen interactions and modulation of cell proliferation.

Pavlik EJ, Katzenellenbogen BS. Pavlik EJ, et al. J Clin Endocrinol Metab. 1978 Aug;47(2):333-44. doi: 10.1210/jcem-47-2-333. J Clin Endocrinol Metab. 1978. PMID: 263301 No abstract available.

4

Effects of estrogen and progesterone on cytoplasmic estrogen receptor and rates of protein synthesis in rat uterus.

Coulson PB, Pavlik EJ. Coulson PB, et al. Among authors: pavlik ej. J Steroid Biochem. 1977 Mar;8(3):205-12. doi: 10.1016/0022-4731(77)90052-8. J Steroid Biochem. 1977. PMID: 859322 No abstract available.

5

Modulation of estrogen receptors in four different target tissues: differential effects of estrogen vs progesterone.

Pavlik EJ, Coulson PB. Pavlik EJ, et al. J Steroid Biochem. 1976 May;7(5):369-76. doi: 10.1016/0022-4731(76)90096-0. J Steroid Biochem. 1976. PMID: 180347 No abstract available.

6

Hydroxylapatite "batch" assay for estrogen receptors: increased sensitivity over present receptor assays.

Pavlik EJ, Coulson PB. Pavlik EJ, et al. J Steroid Biochem. 1976 May;7(5):357-68. doi: 10.1016/0022-4731(76)90095-9. J Steroid Biochem. 1976. PMID: 180346 No abstract available.

7

The stability of the uterine estrogen receptor when complexed with estrogens or antiestrogens.

Pavlik EJ, Katzenellenbogen BS. Pavlik EJ, et al. Mol Pharmacol. 1980 Nov;18(3):406-12. Mol Pharmacol. 1980. PMID: 7464805 No abstract available.

8

Resistance to tamoxifen with persisting sensitivity to estrogen: possible mediation by excessive antiestrogen binding site activity.

Pavlik EJ, Nelson K, Srinivasan S, Powell DE, Kenady DE, DePriest PD, Gallion HH, van Nagell JR Jr. Pavlik EJ, et al. Cancer Res. 1992 Aug 1;52(15):4106-12. Cancer Res. 1992. PMID: 1638522

9

The growth response of BG-1 ovarian carcinoma cells to estradiol, 4OH-tamoxifen, and tamoxifen: evidence for intrinsic antiestrogen activation.

Pavlik EJ, Nelson K, van Nagell JR Jr, Gallion HS, Donaldson ES, DePriest P, Meares K, van Nagell JR 3rd. Pavlik EJ, et al. Gynecol Oncol. 1991 Sep;42(3):245-9. doi: 10.1016/0090-8258(91)90353-7. Gynecol Oncol. 1991. PMID: 1955187

10

Ovarian cancer screening in asymptomatic postmenopausal women by transvaginal sonography.

Van Nagell JR Jr, DePriest PD, Puls LE, Donaldson ES, Gallion HH, Pavlik EJ, Powell DE, Kryscio RJ. Van Nagell JR Jr, et al. Among authors: pavlik ej. Cancer. 1991 Aug 1;68(3):458-62. doi: 10.1002/1097-0142(19910801)68:3<458::aid-cncr2820680303>3.0.co;2-3. Cancer. 1991. PMID: 2065264

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

109 results

Search Page

Filters